Caribou Biosciences

Each year, Caribou is proud to raise money and donate food to support the Alameda County Community Food Bank, a local charity striving to ensure children, adults, and seniors do not worry about where their next meal is coming from. Our team is grateful for their commitment to a hunger-free community. Donate and learn more at: https://lnkd.in/g-reGdiQ

At Caribou, our mission is to develop innovative, transformative therapies for patients with devastating diseases through novel genome editing. Today, we had the privilege of hearing firsthand stories from incredible lupus patient advocates who shared their personal journeys, challenges, and hope with us during our all-hands meeting. A heartfelt thank you to our inspiring guests, Shamekka Marty PMP, CSM and Jennifer Hwang. Your stories have not only deepened our understanding of the disease,?but have reaffirmed the importance of our work and the core Caribou mission. ?#LupusNephritis #CARTcelltherapies #CRISPR #Lupus #Patientadvocacy

At Caribou, our mission is to develop innovative, transformative therapies for patients with devastating diseases through novel genome editing. Today, we had the privilege of hearing firsthand stories from incredible lupus patient advocates who shared their personal journeys, challenges, and hope with us during our all-hands meeting. A heartfelt thank you to our inspiring guests, Shamekka Marty PMP, CSM and Jennifer Hwang. Your stories have not only deepened our understanding of the disease,?but have reaffirmed the importance of our work and the core Caribou mission. ?#LupusNephritis #CARTcelltherapies #CRISPR #Lupus #Patientadvocacy

Tune in for upcoming investor events in December. More details here: https://bit.ly/3V2dptN

Now at #ACR24: Stop by and view our poster presentation where we’re showcasing preclinical data and key elements of the clinical trial design for our CB-010 GALLOP Phase 1 trial in patients with #lupusnephritis and extrarenal #lupus. View the poster here: https://bit.ly/3Ctcvjz

Join our team at #ACR24 tomorrow, as Elizabeth Garner presents a poster highlighting preclinical data that supported the IND clearance of the CB-010 GALLOP Phase 1 clinical trial for patients with #lupusnephritis and extrarenal #lupus. More details: https://bit.ly/3YqvFiE?? #lupus #CARTcelltherapy?

Caribou is focused on rapidly advancing our four clinical-stage programs for oncology and autoimmune diseases as we continue to execute on multiple clinical milestones in 2025. Learn more in our third quarter 2024 financial results and business update: https://bit.ly/3YFDyjf #CRISPR #celltherapy

This month we took some time for connection and reflection at our company event! We gathered to revisit our mission to develop transformative therapies, give back to patients and our community, and be stronger together through team building activities. Learn more about Caribou’s mission and values: https://lnkd.in/evdYJ798 #CRISPR #CellTherapy?

We are gearing up for the upcoming #BIOEurope conference, which is celebrating its 30th anniversary in Stockholm, Sweden next week. Be on the lookout for Caribou’s chief business officer, Ruhi Khan, and stop her to learn more about our #CRISPR edited allogeneic #CARTcelltherapies.

Today, we are featuring Tom Kochy, VP of program strategy, in our leadership series! Learn more about Tom and how his team help guide and develop Caribou’s clinical programs.